An anthocyanin-rich extract from black rice enhances atherosclerotic plaque stabilization in apolipoprotein E-deficient mice

Journal of Nutrition

Volumn 136, Issue 8, 2006, Pages 2220-2225

  Xia, Xiaodong ^a   Ling, Wenhua ^a   Ma, Jing ^a   Xia, Min ^a   Hou, Mengjun ^a   Wang, Qing ^a   Zhu, Huilian ^a   Tang, Zhihong ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHOCYANIN; APOLIPOPROTEIN E; BLACK RICE EXTRACT; COLLAGEN TYPE 1; CYANIDIN 3 GLUCOSIDE; GLUCOSIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERSTITIAL COLLAGENASE; MESSENGER RNA; PEONIDIN 3 GLUCOSIDE; PLANT EXTRACT; SIMVASTATIN; THROMBOPLASTIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLACK RICE; BRACHIOCEPHALIC TRUNK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIETARY INTAKE; IMMUNOHISTOCHEMISTRY; LIPID BLOOD LEVEL; LIPOPROTEIN DEFICIENCY; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; RICE; TRIACYLGLYCEROL BLOOD LEVEL;

ANTHO;

EID: 33746652574     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/136.8.2220     Document Type: Article

References (46)

1. Libby P. Molecular bases of the acute coronary syndromes. Circulation. 1995;91:2844-50.
2. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation. 2001;104:365-72.
3. Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2000;20:1262-75.
4. Van der Wal AC, Becker AE, van der Loos CM, Das PK. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 1994;89:36-44.
5. Zaman AG, Helft G, Worthley SG, Badimon JJ. The role of plaque rupture and thrombosis in coronary artery disease. Atherosclerosis. 2000;149:251-66.
6. Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation. 2004;109:II-2-10.
7. Ambrose JA, Martinez EE. A new paradigm for plaque stabilization. Circulation. 2002;105:2000-4.
8. Stoclet JC, Chataigneau T, Ndiaye M, Oak MH, El Bedoui J, Chataigneau M, Schini-Kerth VB. Vascular protection by dietary polyphenols. Eur J Pharmacol. 2004;500:299-313.
9. Manach C, Mazur A, Scalbert A. Polyphenols and prevention of cardiovascular diseases. Curr Opin Lipidol. 2005;16:77-84.
10. Ling WH, Cheng QX, Ma J, Wang T. Red or black rice decrease atherosclerotic plaque and increase antioxidant status in rabbits. J Nutr. 2001;131:1421-6.
11. Ling WH, Wang LL, Ma J. Supplementation of the black rice outer layer fraction to rabbits decreases atherosclerotic plaque formation and increases antioxidant status. J Nutr. 2002;132:20-6.
12. Xia M, Ling WH, Ma J, Kitts DD, Zawistowsk J. Supplementation of diets with black rice pigment fraction attenuates atherosclerotic plaque formation in apolipoprotein E-deficient mice. J Nutr. 2003;133:744-51.
13. Hu C, Zawistowski J, Ling WH, Kitts DD. Black rice (Oryza sativa L. indica) pigmented fraction suppresses both reactive oxygen species and nitric oxide in chemical and biological model systems. J Agric Food Chem. 2003;51:5271-7.
14. Rosenfeld ME, Polinsky P, Virmani R, Kauser K, Rubanyi G, Schwartz SM. Advanced atherosclerotic lesions in the innominate artery of the apoE knockout mouse. Arterioscler Thromb Vasc Biol. 2000;20:2587-92.
15. Williams H, Johnson JL, Carson KG, Jackson CL. Characteristics of intact and ruptured atherosclerotic plaques in brachiocephalic arteries of apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol. 2002;22:788-92.
16. Johnson J, Carson K, Williams H, Karanam S, Newby A, Angelini G, George S, Jackson C. Plaque rupture after short periods of fat feeding in the apolipoprotein E-knockout mouse: model characterization and effects of pravastatin treatment. Circulation. 2005;111:1422-30.
17. Chandra A, Rana J, Li Y. Separation, identification, quantification, and method validation of anthocyanins in botanical supplement raw materials by HPLC and HPLC-MS. J Agric Food Chem. 2001;49:3515-21.
18. Ramirez-Tortosa C, Andersen OM, Gardner PT, Morrice PC, Wood SG, Duthie SJ, Duthie SJ, Collins AR, Duthie GG. Anthocyanin-rich extract decreases indices of lipid peroxidation and DNA damage in vitamin E-depleted rats. Free Radic Biol Med. 2001;31:1033-7.
19. Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition. ad hoc committee on the reformulation of the AIN-76 rodent diet. J Nutr. 1993;123:1939-51.
20. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470-5.
21. Bea F, Blessing E, Bennett B, Levitz M, Wallace EP, Rosenfeld ME. Simvastatin promotes atherosclerotic plaque stability in apoE-deficient mice independently of lipid lowering. Arterioscler Thromb Vasc Biol. 2002;22:1832-7.
22. Tsuda T, Horio F, Uchida K, Aoki H, Osawa T. Dietary cyanidin 3-O-beta-D-glucoside-rich purple corn color prevents obesity and ameliorates hyperglycemia in mice. J Nutr. 2003;133:2125-30.
23. 0) mice and reduce macrophage atherogenicity. J Nutr. 2005;135:722-8.
24. Adams MR, Golden DL, Register TC, Anthony MS, Hodgin JB, Maeda N, Williams JK. The atheroprotective effect of dietary soy isoflavones in apolipoprotein E-/- mice requires the presence of estrogen receptor-alpha. Arterioscler Thromb Vasc Biol. 2002;22:1859-64.
25. Schmermund A, Erbel R. Unstable coronary plaque and its relation to coronary calcium. Circulation. 2001;104:1682-7.
26. Lafont A. Basic aspects of plaque vulnerability. Heart. 2003;89:1262-7.
27. Davies MJ. Going from immutable to mutable atherosclerotic plaques. Am J Cardiol. 2001;88:2F-9.
28. Shah PK. Pathophysiology of plaque rupture and the concept of plaque stabilization. Cardiol Clin. 2003;21:303-14.
29. Orbe J, Rodriguez JA, Arias R, Belzunce M, Nespereira B, Perez-Ilzarbe M, Roncal C, Paramo JA. Antioxidant vitamins increase the collagen content and reduce MMP-1 in a porcine model of atherosclerosis: implications for plaque stabilization. Atherosclerosis. 2003;167:45-53.
30. Crisby M, Nordin-Fredriksson G, Shah PK, Yano J, Zhu J, Nilsson J. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation. 2001;103:926-33.
31. Aikawa M, Rabkin E, Okada Y, Voglic SJ, Clinton SK, Brinckerhoff CE. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. Circulation. 1998;97:2433-44.
32. Shah PK, Falk E, Badimon JJ, Fernandez-Ortiz A, Mailhac A, Villareal-Levy G, Fallon JT, Regnstrom J, Fuster V. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques: potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation. 1995;92:1565-9.
33. Libby P. What have we learned about the biology of atherosclerosis? The role of inflammation. Am. J. Cardiol. 2001;88:3J-6J.
34. Himber J, Kling D, Fallon JT, Nemerson Y, Riederer MA. In situ localization of tissue factor in human thrombi. Blood. 2002;99:4249-50.
35. Kaikita K, Takeya M, Ogawa H, Suefuji H, Yasue H, Takahashi K. Colocalization of tissue factor and tissue factor pathway inhibitor in coronary atherosclerosis. J Pathol. 1999;188:180-8.
36. Moons AHM, Levi M, Peters RJ. Tissue factor and coronary artery disease. Cardiovasc Res. 2002;53:313-25.
37. Arnold CS, Parker C, Upshaw R, Prydz H, Chand P, Kotian P, Bantia S, Babu YS. The antithrombotic and anti-inflammatory effects of BCX-3607, a small molecule tissue factor/factor VIIa inhibitor. Thromb Res. 2006;117:343-9.
38. Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implication for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A. 1990;87:1620-4.
39. Buttery LD, Springall DR, Chester AH, Evans TJ, Standfield EN, Parums DV, Yacoub MH, Polak JM. Inducible nitric oxide synthase is present within human atherosclerotic lesion and promotes the formation and activity of peroxynitrite. Lab Invest. 1996;75:77-85.
40. Jacobi J, Kristal B, Chezar J, Shaul SM, Sela S. Exogenous superoxide mediates pro-oxidative, proinflammatory, and procoagulatory changes in primary endothelial cell cultures. Free Radic Biol Med. 2005;39:1238-48.
41. Ravindra PV, Narayan MS. Antioxidant activity of the anthocyanin from carrot (Daucus carota) callus culture. Int J Food Sci Nutr. 2003;54:349-55.
42. Garcia-Alonso M, Rimbach G, Rivas-Gonzalo JC, De Pascual-Teresa S. Antioxidant and cellular activities of anthocyanins and their corresponding vitisins A - studies in platelets, monocytes, and human endothelial cells. J Agric Food Chem. 2004;52:3378-84.
43. Libby P, Aikawa M. New insights into plaque stabilisation by lipid lowering. Drugs. 1998;56:9-13.
44. Bucher HC, Griffith LE, Guyatt GH. Systematic review on the risk and benefit of different cholesterol-lowering interventions. Arterioscler Thromb Vasc Biol. 1999;19:187-95.
45. Lefer AM, Scalia R, Lefer DJ. Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease. Cardiovasc Res. 2001;49:281-7.
46. Sparrow CP, Burton CA, Hernandez M, Mundt S, Hassing H, Patel S, Rosa R, Hermanowski-Vosatka A, Wang PR, et al. Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering. Arterioscler Thromb Vasc Biol. 2001;21:115-21.